The initial FDA indication for Lamotrigine was adjunctive therapy for partial seizures (including secondarily generalized tonic clonic seizures) in patients taking enzyme-inducing AEDs. A large percentage of those patients were taking carbamazepine with adjunctive lamotrigine.
The question does not seem appropriate for this board.